nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—ovarian cancer—uterine cancer	0.669	1	CtDrD
Vinorelbine—ABCB1—Progesterone—uterine cancer	0.0203	0.175	CbGbCtD
Vinorelbine—CYP2D6—Progesterone—uterine cancer	0.0192	0.164	CbGbCtD
Vinorelbine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0184	0.158	CbGbCtD
Vinorelbine—ABCB1—Dactinomycin—uterine cancer	0.0161	0.138	CbGbCtD
Vinorelbine—CYP3A4—Progesterone—uterine cancer	0.0122	0.105	CbGbCtD
Vinorelbine—ABCB1—Etoposide—uterine cancer	0.0091	0.0781	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—uterine cancer	0.00621	0.0533	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—uterine cancer	0.00585	0.0502	CbGbCtD
Vinorelbine—CYP3A4—Etoposide—uterine cancer	0.00545	0.0468	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—uterine cancer	0.00372	0.0319	CbGbCtD
Vinorelbine—TUBB4B—oviduct—uterine cancer	0.00305	0.0571	CbGeAlD
Vinorelbine—TUBB1—decidua—uterine cancer	0.00149	0.0279	CbGeAlD
Vinorelbine—TUBB2B—myometrium—uterine cancer	0.00121	0.0227	CbGeAlD
Vinorelbine—TUBB—myometrium—uterine cancer	0.00114	0.0214	CbGeAlD
Vinorelbine—TUBB2A—myometrium—uterine cancer	0.00114	0.0213	CbGeAlD
Vinorelbine—TUBB6—myometrium—uterine cancer	0.00112	0.021	CbGeAlD
Vinorelbine—TUBB4B—myometrium—uterine cancer	0.000976	0.0183	CbGeAlD
Vinorelbine—TUBB4A—uterine cervix—uterine cancer	0.000974	0.0182	CbGeAlD
Vinorelbine—TUBB2B—uterine cervix—uterine cancer	0.000941	0.0176	CbGeAlD
Vinorelbine—TUBB4A—renal system—uterine cancer	0.000911	0.0171	CbGeAlD
Vinorelbine—TUBB—uterine cervix—uterine cancer	0.000891	0.0167	CbGeAlD
Vinorelbine—TUBB2A—uterine cervix—uterine cancer	0.000886	0.0166	CbGeAlD
Vinorelbine—TUBB6—epithelium—uterine cancer	0.000881	0.0165	CbGeAlD
Vinorelbine—TUBB2B—renal system—uterine cancer	0.000881	0.0165	CbGeAlD
Vinorelbine—TUBB6—uterine cervix—uterine cancer	0.000874	0.0164	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—uterine cancer	0.000866	0.0162	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—uterine cancer	0.000861	0.0161	CbGeAlD
Vinorelbine—TUBB2B—endometrium—uterine cancer	0.000851	0.0159	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—uterine cancer	0.000849	0.0159	CbGeAlD
Vinorelbine—TUBB—decidua—uterine cancer	0.000849	0.0159	CbGeAlD
Vinorelbine—TUBB2A—decidua—uterine cancer	0.000844	0.0158	CbGeAlD
Vinorelbine—TUBB6—decidua—uterine cancer	0.000833	0.0156	CbGeAlD
Vinorelbine—TUBB2B—mammalian vulva—uterine cancer	0.000823	0.0154	CbGeAlD
Vinorelbine—TUBB6—renal system—uterine cancer	0.000818	0.0153	CbGeAlD
Vinorelbine—TUBB4A—uterus—uterine cancer	0.000812	0.0152	CbGeAlD
Vinorelbine—TUBB—endometrium—uterine cancer	0.000806	0.0151	CbGeAlD
Vinorelbine—TUBB2A—endometrium—uterine cancer	0.000801	0.015	CbGeAlD
Vinorelbine—TUBB6—endometrium—uterine cancer	0.00079	0.0148	CbGeAlD
Vinorelbine—TUBB—mammalian vulva—uterine cancer	0.000779	0.0146	CbGeAlD
Vinorelbine—TUBB2A—mammalian vulva—uterine cancer	0.000775	0.0145	CbGeAlD
Vinorelbine—TUBB6—mammalian vulva—uterine cancer	0.000765	0.0143	CbGeAlD
Vinorelbine—TUBB4B—uterine cervix—uterine cancer	0.00076	0.0142	CbGeAlD
Vinorelbine—TUBB—uterus—uterine cancer	0.000742	0.0139	CbGeAlD
Vinorelbine—TUBB2A—uterus—uterine cancer	0.000738	0.0138	CbGeAlD
Vinorelbine—TUBB4B—smooth muscle tissue—uterine cancer	0.000738	0.0138	CbGeAlD
Vinorelbine—TUBB4A—female reproductive system—uterine cancer	0.00073	0.0137	CbGeAlD
Vinorelbine—TUBB6—uterus—uterine cancer	0.000728	0.0136	CbGeAlD
Vinorelbine—TUBB4B—decidua—uterine cancer	0.000724	0.0136	CbGeAlD
Vinorelbine—TUBB4B—renal system—uterine cancer	0.000711	0.0133	CbGeAlD
Vinorelbine—TUBB2B—female reproductive system—uterine cancer	0.000705	0.0132	CbGeAlD
Vinorelbine—TUBB4B—endometrium—uterine cancer	0.000687	0.0129	CbGeAlD
Vinorelbine—TUBB4B—mammalian vulva—uterine cancer	0.000665	0.0124	CbGeAlD
Vinorelbine—TUBB4A—female gonad—uterine cancer	0.000664	0.0124	CbGeAlD
Vinorelbine—TUBB2A—female reproductive system—uterine cancer	0.000664	0.0124	CbGeAlD
Vinorelbine—TUBB6—female reproductive system—uterine cancer	0.000655	0.0123	CbGeAlD
Vinorelbine—TUBB2B—female gonad—uterine cancer	0.000642	0.012	CbGeAlD
Vinorelbine—TUBB2B—vagina—uterine cancer	0.000638	0.0119	CbGeAlD
Vinorelbine—TUBB4B—uterus—uterine cancer	0.000633	0.0119	CbGeAlD
Vinorelbine—TUBB—female gonad—uterine cancer	0.000607	0.0114	CbGeAlD
Vinorelbine—TUBB2A—female gonad—uterine cancer	0.000604	0.0113	CbGeAlD
Vinorelbine—TUBB—vagina—uterine cancer	0.000604	0.0113	CbGeAlD
Vinorelbine—TUBB2A—vagina—uterine cancer	0.0006	0.0112	CbGeAlD
Vinorelbine—TUBB6—female gonad—uterine cancer	0.000596	0.0112	CbGeAlD
Vinorelbine—TUBB6—vagina—uterine cancer	0.000592	0.0111	CbGeAlD
Vinorelbine—TUBB4B—female reproductive system—uterine cancer	0.000569	0.0107	CbGeAlD
Vinorelbine—TUBB4B—female gonad—uterine cancer	0.000518	0.0097	CbGeAlD
Vinorelbine—TUBB4B—vagina—uterine cancer	0.000515	0.00964	CbGeAlD
Vinorelbine—TUBB4A—lymph node—uterine cancer	0.000427	0.00799	CbGeAlD
Vinorelbine—TUBB2B—lymph node—uterine cancer	0.000413	0.00773	CbGeAlD
Vinorelbine—TUBB—lymph node—uterine cancer	0.00039	0.00731	CbGeAlD
Vinorelbine—TUBB2A—lymph node—uterine cancer	0.000388	0.00727	CbGeAlD
Vinorelbine—TUBB6—lymph node—uterine cancer	0.000383	0.00717	CbGeAlD
Vinorelbine—TUBB4B—lymph node—uterine cancer	0.000333	0.00624	CbGeAlD
Vinorelbine—CYP3A4—renal system—uterine cancer	0.000292	0.00547	CbGeAlD
Vinorelbine—CYP2D6—renal system—uterine cancer	0.000287	0.00538	CbGeAlD
Vinorelbine—ABCB1—myometrium—uterine cancer	0.000284	0.00532	CbGeAlD
Vinorelbine—CYP3A4—female reproductive system—uterine cancer	0.000234	0.00438	CbGeAlD
Vinorelbine—CYP2D6—female reproductive system—uterine cancer	0.00023	0.00431	CbGeAlD
Vinorelbine—ABCB1—epithelium—uterine cancer	0.000223	0.00417	CbGeAlD
Vinorelbine—ABCB1—uterine cervix—uterine cancer	0.000221	0.00414	CbGeAlD
Vinorelbine—TUBB2B—Metabolism of proteins—TSPYL2—uterine cancer	0.000214	0.00624	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—TSPYL2—uterine cancer	0.000214	0.00624	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—YWHAE—uterine cancer	0.000213	0.00622	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.000211	0.00613	CbGpPWpGaD
Vinorelbine—ABCB1—decidua—uterine cancer	0.00021	0.00394	CbGeAlD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—YWHAE—uterine cancer	0.00021	0.00613	CbGpPWpGaD
Vinorelbine—CYP2D6—female gonad—uterine cancer	0.000209	0.00392	CbGeAlD
Vinorelbine—TUBB3—Metabolism of proteins—TSPYL2—uterine cancer	0.000207	0.00602	CbGpPWpGaD
Vinorelbine—ABCB1—renal system—uterine cancer	0.000207	0.00387	CbGeAlD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.000206	0.006	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—TSPYL2—uterine cancer	0.0002	0.00583	CbGpPWpGaD
Vinorelbine—ABCB1—endometrium—uterine cancer	0.0002	0.00374	CbGeAlD
Vinorelbine—TUBB1—Metabolism of proteins—TSPYL2—uterine cancer	0.000196	0.0057	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—YWHAE—uterine cancer	0.000195	0.00569	CbGpPWpGaD
Vinorelbine—ABCB1—mammalian vulva—uterine cancer	0.000193	0.00362	CbGeAlD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—YWHAE—uterine cancer	0.000192	0.00561	CbGpPWpGaD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—EP300—uterine cancer	0.00019	0.00554	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.000185	0.00539	CbGpPWpGaD
Vinorelbine—ABCB1—uterus—uterine cancer	0.000184	0.00345	CbGeAlD
Vinorelbine—TUBB—Cell Cycle—MLH3—uterine cancer	0.000184	0.00536	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—TSPYL2—uterine cancer	0.000176	0.00512	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.000169	0.00493	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000166	0.00484	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000166	0.00484	CbGpPWpGaD
Vinorelbine—ABCB1—female reproductive system—uterine cancer	0.000166	0.0031	CbGeAlD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000165	0.0048	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—TSPYL2—uterine cancer	0.000161	0.00468	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.00016	0.00468	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000155	0.00453	CbGpPWpGaD
Vinorelbine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000153	0.00121	CcSEcCtD
Vinorelbine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000153	0.00121	CcSEcCtD
Vinorelbine—Pulmonary oedema—Epirubicin—uterine cancer	0.000153	0.00121	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—MLH3—uterine cancer	0.000152	0.00444	CbGpPWpGaD
Vinorelbine—Skin exfoliation—Doxorubicin—uterine cancer	0.000152	0.0012	CcSEcCtD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000152	0.00443	CbGpPWpGaD
Vinorelbine—Pruritus—Progesterone—uterine cancer	0.000151	0.00119	CcSEcCtD
Vinorelbine—ABCB1—female gonad—uterine cancer	0.000151	0.00282	CbGeAlD
Vinorelbine—Infection—Dactinomycin—uterine cancer	0.00015	0.00118	CcSEcCtD
Vinorelbine—ABCB1—vagina—uterine cancer	0.00015	0.0028	CbGeAlD
Vinorelbine—Aplastic anaemia—Doxorubicin—uterine cancer	0.000149	0.00118	CcSEcCtD
Vinorelbine—Sepsis—Epirubicin—uterine cancer	0.000149	0.00118	CcSEcCtD
Vinorelbine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000148	0.00117	CcSEcCtD
Vinorelbine—Diarrhoea—Progesterone—uterine cancer	0.000146	0.00115	CcSEcCtD
Vinorelbine—Oesophagitis—Doxorubicin—uterine cancer	0.000145	0.00115	CcSEcCtD
Vinorelbine—Phlebitis—Epirubicin—uterine cancer	0.000145	0.00114	CcSEcCtD
Vinorelbine—Thrombophlebitis—Epirubicin—uterine cancer	0.000144	0.00114	CcSEcCtD
Vinorelbine—Anorexia—Dactinomycin—uterine cancer	0.000144	0.00114	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000144	0.00419	CbGpPWpGaD
Vinorelbine—Cardiac disorder—Etoposide—uterine cancer	0.000143	0.00113	CcSEcCtD
Vinorelbine—Flushing—Etoposide—uterine cancer	0.000143	0.00113	CcSEcCtD
Vinorelbine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000143	0.00113	CcSEcCtD
Vinorelbine—Pulmonary oedema—Doxorubicin—uterine cancer	0.000142	0.00112	CcSEcCtD
Vinorelbine—Dizziness—Progesterone—uterine cancer	0.000142	0.00112	CcSEcCtD
Vinorelbine—Angiopathy—Etoposide—uterine cancer	0.00014	0.0011	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—MLH3—uterine cancer	0.000139	0.00406	CbGpPWpGaD
Vinorelbine—Immune system disorder—Etoposide—uterine cancer	0.000139	0.0011	CcSEcCtD
Vinorelbine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.0011	CcSEcCtD
Vinorelbine—Hepatic failure—Epirubicin—uterine cancer	0.000139	0.0011	CcSEcCtD
Vinorelbine—Mediastinal disorder—Etoposide—uterine cancer	0.000139	0.00109	CcSEcCtD
Vinorelbine—Sepsis—Doxorubicin—uterine cancer	0.000138	0.00109	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000138	0.00109	CcSEcCtD
Vinorelbine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00108	CcSEcCtD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000136	0.00398	CbGpPWpGaD
Vinorelbine—Alopecia—Etoposide—uterine cancer	0.000136	0.00107	CcSEcCtD
Vinorelbine—Vomiting—Progesterone—uterine cancer	0.000136	0.00107	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—uterine cancer	0.000136	0.00397	CbGpPWpGaD
Vinorelbine—Rash—Progesterone—uterine cancer	0.000135	0.00106	CcSEcCtD
Vinorelbine—Dermatitis—Progesterone—uterine cancer	0.000135	0.00106	CcSEcCtD
Vinorelbine—Phlebitis—Doxorubicin—uterine cancer	0.000134	0.00106	CcSEcCtD
Vinorelbine—Headache—Progesterone—uterine cancer	0.000134	0.00106	CcSEcCtD
Vinorelbine—Thrombophlebitis—Doxorubicin—uterine cancer	0.000134	0.00105	CcSEcCtD
Vinorelbine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000133	0.00105	CcSEcCtD
Vinorelbine—Decreased appetite—Dactinomycin—uterine cancer	0.000132	0.00104	CcSEcCtD
Vinorelbine—Dermatitis bullous—Epirubicin—uterine cancer	0.000131	0.00103	CcSEcCtD
Vinorelbine—Fatigue—Dactinomycin—uterine cancer	0.00013	0.00103	CcSEcCtD
Vinorelbine—Back pain—Etoposide—uterine cancer	0.00013	0.00102	CcSEcCtD
Vinorelbine—Pain—Dactinomycin—uterine cancer	0.000129	0.00102	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000129	0.00376	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000129	0.00376	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—NDC80—uterine cancer	0.000129	0.00375	CbGpPWpGaD
Vinorelbine—Hepatic failure—Doxorubicin—uterine cancer	0.000129	0.00101	CcSEcCtD
Vinorelbine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000128	0.00101	CcSEcCtD
Vinorelbine—Cardiac failure—Epirubicin—uterine cancer	0.000128	0.00101	CcSEcCtD
Vinorelbine—Lethargy—Epirubicin—uterine cancer	0.000127	0.001	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000127	0.001	CcSEcCtD
Vinorelbine—Nausea—Progesterone—uterine cancer	0.000127	0.001	CcSEcCtD
Vinorelbine—Hyponatraemia—Epirubicin—uterine cancer	0.000125	0.000988	CcSEcCtD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000125	0.00364	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Dactinomycin—uterine cancer	0.000125	0.000983	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000125	0.00363	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Etoposide—uterine cancer	0.000125	0.000981	CcSEcCtD
Vinorelbine—Anaemia—Etoposide—uterine cancer	0.000124	0.000978	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000124	0.000975	CcSEcCtD
Vinorelbine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000123	0.000972	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000122	0.00357	CbGpPWpGaD
Vinorelbine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.000964	CcSEcCtD
Vinorelbine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.000963	CcSEcCtD
Vinorelbine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.000958	CcSEcCtD
Vinorelbine—Malaise—Etoposide—uterine cancer	0.000121	0.000954	CcSEcCtD
Vinorelbine—Dermatitis bullous—Doxorubicin—uterine cancer	0.000121	0.000953	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000121	0.00352	CbGpPWpGaD
Vinorelbine—Vertigo—Etoposide—uterine cancer	0.000121	0.00095	CcSEcCtD
Vinorelbine—Leukopenia—Etoposide—uterine cancer	0.00012	0.000947	CcSEcCtD
Vinorelbine—Abdominal pain—Dactinomycin—uterine cancer	0.00012	0.000943	CcSEcCtD
Vinorelbine—Body temperature increased—Dactinomycin—uterine cancer	0.00012	0.000943	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000119	0.00347	CbGpPWpGaD
Vinorelbine—Cardiac failure—Doxorubicin—uterine cancer	0.000118	0.000933	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000118	0.00344	CbGpPWpGaD
Vinorelbine—Lethargy—Doxorubicin—uterine cancer	0.000118	0.00093	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000118	0.00093	CcSEcCtD
Vinorelbine—Cough—Etoposide—uterine cancer	0.000117	0.000923	CcSEcCtD
Vinorelbine—Blood creatinine increased—Epirubicin—uterine cancer	0.000117	0.000922	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—uterine cancer	0.000116	0.000915	CcSEcCtD
Vinorelbine—Hypertension—Etoposide—uterine cancer	0.000116	0.000913	CcSEcCtD
Vinorelbine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000115	0.000908	CcSEcCtD
Vinorelbine—Chest pain—Etoposide—uterine cancer	0.000114	0.0009	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000113	0.000894	CcSEcCtD
Vinorelbine—Discomfort—Etoposide—uterine cancer	0.000113	0.00089	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000112	0.000886	CcSEcCtD
Vinorelbine—Hypersensitivity—Dactinomycin—uterine cancer	0.000111	0.000879	CcSEcCtD
Vinorelbine—Muscular weakness—Epirubicin—uterine cancer	0.00011	0.000868	CcSEcCtD
Vinorelbine—Anaphylactic shock—Etoposide—uterine cancer	0.00011	0.000863	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—POLD1—uterine cancer	0.000109	0.00319	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000109	0.00318	CbGpPWpGaD
Vinorelbine—Infection—Etoposide—uterine cancer	0.000109	0.000858	CcSEcCtD
Vinorelbine—Asthenia—Dactinomycin—uterine cancer	0.000109	0.000856	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000108	0.000853	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000108	0.00315	CbGpPWpGaD
Vinorelbine—Dysphagia—Epirubicin—uterine cancer	0.000108	0.000851	CcSEcCtD
Vinorelbine—Thrombocytopenia—Etoposide—uterine cancer	0.000107	0.000845	CcSEcCtD
Vinorelbine—Tachycardia—Etoposide—uterine cancer	0.000107	0.000842	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—NDC80—uterine cancer	0.000107	0.00311	CbGpPWpGaD
Vinorelbine—Skin disorder—Etoposide—uterine cancer	0.000106	0.000838	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000106	0.00309	CbGpPWpGaD
Vinorelbine—Pancreatitis—Epirubicin—uterine cancer	0.000106	0.000834	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000106	0.00308	CbGpPWpGaD
Vinorelbine—Angina pectoris—Epirubicin—uterine cancer	0.000105	0.000829	CcSEcCtD
Vinorelbine—Anorexia—Etoposide—uterine cancer	0.000104	0.000823	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000104	0.00304	CbGpPWpGaD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000104	0.00082	CcSEcCtD
Vinorelbine—Diarrhoea—Dactinomycin—uterine cancer	0.000104	0.000816	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—uterine cancer	0.000103	0.000808	CcSEcCtD
Vinorelbine—Hypotension—Etoposide—uterine cancer	0.000102	0.000807	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000102	0.00297	CbGpPWpGaD
Vinorelbine—Muscular weakness—Doxorubicin—uterine cancer	0.000102	0.000803	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000101	0.00295	CbGpPWpGaD
Vinorelbine—Neutropenia—Epirubicin—uterine cancer	0.000101	0.000796	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—uterine cancer	9.99e-05	0.000787	CcSEcCtD
Vinorelbine—Paraesthesia—Etoposide—uterine cancer	9.83e-05	0.000775	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—uterine cancer	9.79e-05	0.000772	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—uterine cancer	9.77e-05	0.00077	CcSEcCtD
Vinorelbine—Dyspnoea—Etoposide—uterine cancer	9.76e-05	0.00077	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—NDC80—uterine cancer	9.75e-05	0.00284	CbGpPWpGaD
Vinorelbine—Angina pectoris—Doxorubicin—uterine cancer	9.73e-05	0.000767	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ABCC9—uterine cancer	9.69e-05	0.00282	CbGpPWpGaD
Vinorelbine—ABCB1—lymph node—uterine cancer	9.68e-05	0.00181	CbGeAlD
Vinorelbine—Pneumonia—Epirubicin—uterine cancer	9.68e-05	0.000763	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—uterine cancer	9.63e-05	0.000759	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—uterine cancer	9.63e-05	0.000759	CcSEcCtD
Vinorelbine—Vomiting—Dactinomycin—uterine cancer	9.62e-05	0.000758	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—INHBA—uterine cancer	9.56e-05	0.00279	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—INHBA—uterine cancer	9.56e-05	0.00279	CbGpPWpGaD
Vinorelbine—Rash—Dactinomycin—uterine cancer	9.54e-05	0.000752	CcSEcCtD
Vinorelbine—Decreased appetite—Etoposide—uterine cancer	9.52e-05	0.00075	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—uterine cancer	9.49e-05	0.000748	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Etoposide—uterine cancer	9.46e-05	0.000745	CcSEcCtD
Vinorelbine—Fatigue—Etoposide—uterine cancer	9.44e-05	0.000744	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—uterine cancer	9.44e-05	0.000744	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—uterine cancer	9.38e-05	0.000739	CcSEcCtD
Vinorelbine—Constipation—Etoposide—uterine cancer	9.37e-05	0.000738	CcSEcCtD
Vinorelbine—Pain—Etoposide—uterine cancer	9.37e-05	0.000738	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—uterine cancer	9.34e-05	0.000736	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—POLD1—uterine cancer	9.27e-05	0.0027	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—INHBA—uterine cancer	9.23e-05	0.00269	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RRM2—uterine cancer	9.12e-05	0.00266	CbGpPWpGaD
Vinorelbine—Hepatobiliary disease—Epirubicin—uterine cancer	9.1e-05	0.000717	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—POLD1—uterine cancer	9.07e-05	0.00264	CbGpPWpGaD
Vinorelbine—Weight decreased—Doxorubicin—uterine cancer	9.04e-05	0.000712	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—uterine cancer	9.02e-05	0.000711	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—MME—uterine cancer	8.99e-05	0.00262	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MME—uterine cancer	8.99e-05	0.00262	CbGpPWpGaD
Vinorelbine—Nausea—Dactinomycin—uterine cancer	8.99e-05	0.000708	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—uterine cancer	8.98e-05	0.000708	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—uterine cancer	8.96e-05	0.000706	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Etoposide—uterine cancer	8.96e-05	0.000706	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—INHBA—uterine cancer	8.94e-05	0.00261	CbGpPWpGaD
Vinorelbine—Infestation—Doxorubicin—uterine cancer	8.91e-05	0.000702	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—uterine cancer	8.91e-05	0.000702	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—INHBA—uterine cancer	8.74e-05	0.00255	CbGpPWpGaD
Vinorelbine—Neuropathy peripheral—Doxorubicin—uterine cancer	8.73e-05	0.000688	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—uterine cancer	8.7e-05	0.000686	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—MME—uterine cancer	8.68e-05	0.00253	CbGpPWpGaD
Vinorelbine—Stomatitis—Doxorubicin—uterine cancer	8.68e-05	0.000684	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—uterine cancer	8.66e-05	0.000682	CcSEcCtD
Vinorelbine—Abdominal pain—Etoposide—uterine cancer	8.66e-05	0.000682	CcSEcCtD
Vinorelbine—TUBB—G2/M Transition—EP300—uterine cancer	8.6e-05	0.00251	CbGpPWpGaD
Vinorelbine—Hypoaesthesia—Epirubicin—uterine cancer	8.6e-05	0.000678	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.56e-05	0.00249	CbGpPWpGaD
Vinorelbine—Connective tissue disorder—Epirubicin—uterine cancer	8.49e-05	0.000669	CcSEcCtD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—EP300—uterine cancer	8.48e-05	0.00247	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RRM2—uterine cancer	8.45e-05	0.00246	CbGpPWpGaD
Vinorelbine—Hepatobiliary disease—Doxorubicin—uterine cancer	8.42e-05	0.000664	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—MME—uterine cancer	8.41e-05	0.00245	CbGpPWpGaD
Vinorelbine—Agranulocytosis—Doxorubicin—uterine cancer	8.31e-05	0.000655	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—POLD1—uterine cancer	8.29e-05	0.00242	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MME—uterine cancer	8.22e-05	0.0024	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—YWHAE—uterine cancer	8.19e-05	0.00239	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MLH1—uterine cancer	8.1e-05	0.00236	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Etoposide—uterine cancer	8.07e-05	0.000636	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	8.07e-05	0.00235	CbGpPWpGaD
Vinorelbine—Flushing—Epirubicin—uterine cancer	8.02e-05	0.000632	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—uterine cancer	8.02e-05	0.000632	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—uterine cancer	7.96e-05	0.000627	CcSEcCtD
Vinorelbine—Asthenia—Etoposide—uterine cancer	7.86e-05	0.000619	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—uterine cancer	7.86e-05	0.000619	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—INHBA—uterine cancer	7.85e-05	0.00229	CbGpPWpGaD
Vinorelbine—Angiopathy—Epirubicin—uterine cancer	7.84e-05	0.000618	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—uterine cancer	7.8e-05	0.000615	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—uterine cancer	7.79e-05	0.000614	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.77e-05	0.00226	CbGpPWpGaD
Vinorelbine—Pruritus—Etoposide—uterine cancer	7.75e-05	0.000611	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RRM2—uterine cancer	7.73e-05	0.00225	CbGpPWpGaD
Vinorelbine—Arrhythmia—Epirubicin—uterine cancer	7.72e-05	0.000608	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.67e-05	0.00223	CbGpPWpGaD
Vinorelbine—Alopecia—Epirubicin—uterine cancer	7.64e-05	0.000602	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—RRM2—uterine cancer	7.56e-05	0.0022	CbGpPWpGaD
Vinorelbine—Erythema—Epirubicin—uterine cancer	7.52e-05	0.000593	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—uterine cancer	7.52e-05	0.000593	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	7.5e-05	0.00218	CbGpPWpGaD
Vinorelbine—Diarrhoea—Etoposide—uterine cancer	7.49e-05	0.000591	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—uterine cancer	7.42e-05	0.000585	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—uterine cancer	7.42e-05	0.000585	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—MME—uterine cancer	7.38e-05	0.00215	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—YWHAE—uterine cancer	7.33e-05	0.00213	CbGpPWpGaD
Vinorelbine—Back pain—Epirubicin—uterine cancer	7.28e-05	0.000573	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—uterine cancer	7.25e-05	0.000572	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—uterine cancer	7.24e-05	0.000571	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—uterine cancer	7.22e-05	0.000569	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—uterine cancer	7.21e-05	0.000568	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—INHBA—uterine cancer	7.18e-05	0.00209	CbGpPWpGaD
Vinorelbine—Arrhythmia—Doxorubicin—uterine cancer	7.14e-05	0.000563	CcSEcCtD
Vinorelbine—TUBB4A—G2/M Transition—EP300—uterine cancer	7.13e-05	0.00208	CbGpPWpGaD
Vinorelbine—Alopecia—Doxorubicin—uterine cancer	7.07e-05	0.000557	CcSEcCtD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—EP300—uterine cancer	7.03e-05	0.00205	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Epirubicin—uterine cancer	6.98e-05	0.00055	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—uterine cancer	6.96e-05	0.000549	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—uterine cancer	6.96e-05	0.000549	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—uterine cancer	6.96e-05	0.000549	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—uterine cancer	6.95e-05	0.000548	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—RRM2—uterine cancer	6.91e-05	0.00201	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	6.91e-05	0.00201	CbGpPWpGaD
Vinorelbine—Rash—Etoposide—uterine cancer	6.91e-05	0.000544	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—uterine cancer	6.9e-05	0.000544	CcSEcCtD
Vinorelbine—Headache—Etoposide—uterine cancer	6.86e-05	0.000541	CcSEcCtD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6.82e-05	0.00199	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—YWHAE—uterine cancer	6.79e-05	0.00198	CbGpPWpGaD
Vinorelbine—Malaise—Epirubicin—uterine cancer	6.78e-05	0.000535	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—uterine cancer	6.76e-05	0.000533	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—MME—uterine cancer	6.75e-05	0.00197	CbGpPWpGaD
Vinorelbine—Leukopenia—Epirubicin—uterine cancer	6.73e-05	0.000531	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—uterine cancer	6.73e-05	0.000531	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—MLH1—uterine cancer	6.71e-05	0.00196	CbGpPWpGaD
Vinorelbine—Palpitations—Epirubicin—uterine cancer	6.65e-05	0.000524	CcSEcCtD
Vinorelbine—Cough—Epirubicin—uterine cancer	6.56e-05	0.000517	CcSEcCtD
Vinorelbine—TUBB4B—G2/M Transition—EP300—uterine cancer	6.52e-05	0.0019	CbGpPWpGaD
Vinorelbine—Nausea—Etoposide—uterine cancer	6.51e-05	0.000513	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—uterine cancer	6.49e-05	0.000512	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—uterine cancer	6.46e-05	0.000509	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—uterine cancer	6.43e-05	0.000507	CcSEcCtD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—EP300—uterine cancer	6.43e-05	0.00187	CbGpPWpGaD
Vinorelbine—Chest pain—Epirubicin—uterine cancer	6.4e-05	0.000505	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—uterine cancer	6.4e-05	0.000505	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—uterine cancer	6.4e-05	0.000505	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.36e-05	0.000501	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—uterine cancer	6.33e-05	0.000499	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.3e-05	0.00184	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	6.28e-05	0.00183	CbGpPWpGaD
Vinorelbine—Malaise—Doxorubicin—uterine cancer	6.28e-05	0.000495	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	6.25e-05	0.00182	CbGpPWpGaD
Vinorelbine—Vertigo—Doxorubicin—uterine cancer	6.25e-05	0.000493	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—uterine cancer	6.23e-05	0.000491	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—YWHAE—uterine cancer	6.21e-05	0.00181	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2B—uterine cancer	6.15e-05	0.00179	CbGpPWpGaD
Vinorelbine—Palpitations—Doxorubicin—uterine cancer	6.15e-05	0.000485	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—uterine cancer	6.14e-05	0.000484	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—MLH1—uterine cancer	6.14e-05	0.00179	CbGpPWpGaD
Vinorelbine—Infection—Epirubicin—uterine cancer	6.1e-05	0.000481	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—uterine cancer	6.07e-05	0.000479	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—YWHAE—uterine cancer	6.07e-05	0.00177	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	6.05e-05	0.00176	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Epirubicin—uterine cancer	6.02e-05	0.000474	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—uterine cancer	6.01e-05	0.000474	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—uterine cancer	6.01e-05	0.000474	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—uterine cancer	5.99e-05	0.000472	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—uterine cancer	5.96e-05	0.00047	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—uterine cancer	5.93e-05	0.000467	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—uterine cancer	5.93e-05	0.000467	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—uterine cancer	5.93e-05	0.000467	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—FBXW7—uterine cancer	5.91e-05	0.00172	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—FBXW7—uterine cancer	5.91e-05	0.00172	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.88e-05	0.000464	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—uterine cancer	5.85e-05	0.000461	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—uterine cancer	5.85e-05	0.000461	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—uterine cancer	5.74e-05	0.000452	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—FBXW7—uterine cancer	5.7e-05	0.00166	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Doxorubicin—uterine cancer	5.68e-05	0.000448	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—uterine cancer	5.64e-05	0.000445	CcSEcCtD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	5.6e-05	0.00163	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.59e-05	0.000441	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—uterine cancer	5.57e-05	0.000439	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—uterine cancer	5.56e-05	0.000438	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—YWHAE—uterine cancer	5.55e-05	0.00162	CbGpPWpGaD
Vinorelbine—Tachycardia—Doxorubicin—uterine cancer	5.54e-05	0.000437	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—FBXW7—uterine cancer	5.53e-05	0.00161	CbGpPWpGaD
Vinorelbine—Skin disorder—Doxorubicin—uterine cancer	5.52e-05	0.000435	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—uterine cancer	5.51e-05	0.000434	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	5.5e-05	0.0016	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2B—uterine cancer	5.5e-05	0.0016	CbGpPWpGaD
Vinorelbine—Dyspnoea—Epirubicin—uterine cancer	5.47e-05	0.000431	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—uterine cancer	5.41e-05	0.000427	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—FBXW7—uterine cancer	5.4e-05	0.00157	CbGpPWpGaD
Vinorelbine—Decreased appetite—Epirubicin—uterine cancer	5.34e-05	0.000421	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—BIRC5—uterine cancer	5.31e-05	0.00155	CbGpPWpGaD
Vinorelbine—Hypotension—Doxorubicin—uterine cancer	5.31e-05	0.000418	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—uterine cancer	5.3e-05	0.000418	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—uterine cancer	5.29e-05	0.000417	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	5.27e-05	0.00154	CbGpPWpGaD
Vinorelbine—Constipation—Epirubicin—uterine cancer	5.25e-05	0.000414	CcSEcCtD
Vinorelbine—Pain—Epirubicin—uterine cancer	5.25e-05	0.000414	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.18e-05	0.000408	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—uterine cancer	5.1e-05	0.000402	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2B—uterine cancer	5.1e-05	0.00149	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.08e-05	0.00148	CbGpPWpGaD
Vinorelbine—Dyspnoea—Doxorubicin—uterine cancer	5.06e-05	0.000399	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—uterine cancer	5.06e-05	0.000399	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—uterine cancer	5.02e-05	0.000396	CcSEcCtD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.01e-05	0.00146	CbGpPWpGaD
Vinorelbine—Decreased appetite—Doxorubicin—uterine cancer	4.94e-05	0.000389	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.9e-05	0.000387	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	4.9e-05	0.00143	CbGpPWpGaD
Vinorelbine—Fatigue—Doxorubicin—uterine cancer	4.9e-05	0.000386	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—uterine cancer	4.88e-05	0.000384	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—uterine cancer	4.86e-05	0.000383	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—uterine cancer	4.86e-05	0.000383	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—uterine cancer	4.85e-05	0.000382	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—uterine cancer	4.85e-05	0.000382	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—FBXW7—uterine cancer	4.85e-05	0.00141	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	4.83e-05	0.00141	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—BIRC5—uterine cancer	4.75e-05	0.00138	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Doxorubicin—uterine cancer	4.68e-05	0.000369	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4.66e-05	0.00136	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Doxorubicin—uterine cancer	4.64e-05	0.000366	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2B—uterine cancer	4.56e-05	0.00133	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	4.55e-05	0.00133	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Epirubicin—uterine cancer	4.52e-05	0.000356	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—uterine cancer	4.51e-05	0.000356	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—uterine cancer	4.49e-05	0.000354	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—uterine cancer	4.49e-05	0.000354	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	4.49e-05	0.00131	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—FBXW7—uterine cancer	4.44e-05	0.00129	CbGpPWpGaD
Vinorelbine—Asthenia—Epirubicin—uterine cancer	4.4e-05	0.000347	CcSEcCtD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	4.4e-05	0.00128	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—BIRC5—uterine cancer	4.4e-05	0.00128	CbGpPWpGaD
Vinorelbine—Pruritus—Epirubicin—uterine cancer	4.34e-05	0.000342	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	4.24e-05	0.00123	CbGpPWpGaD
Vinorelbine—Diarrhoea—Epirubicin—uterine cancer	4.2e-05	0.000331	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—uterine cancer	4.19e-05	0.00033	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2B—uterine cancer	4.17e-05	0.00121	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.12e-05	0.0012	CbGpPWpGaD
Vinorelbine—Asthenia—Doxorubicin—uterine cancer	4.08e-05	0.000321	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—uterine cancer	4.06e-05	0.00032	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—BIRC5—uterine cancer	4.02e-05	0.00117	CbGpPWpGaD
Vinorelbine—Pruritus—Doxorubicin—uterine cancer	4.02e-05	0.000317	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—BIRC5—uterine cancer	3.93e-05	0.00115	CbGpPWpGaD
Vinorelbine—Vomiting—Epirubicin—uterine cancer	3.9e-05	0.000308	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—uterine cancer	3.89e-05	0.000306	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.88e-05	0.00113	CbGpPWpGaD
Vinorelbine—Rash—Epirubicin—uterine cancer	3.87e-05	0.000305	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—uterine cancer	3.87e-05	0.000305	CcSEcCtD
Vinorelbine—Headache—Epirubicin—uterine cancer	3.85e-05	0.000303	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—uterine cancer	3.76e-05	0.000296	CcSEcCtD
Vinorelbine—Nausea—Epirubicin—uterine cancer	3.65e-05	0.000287	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—uterine cancer	3.61e-05	0.000285	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—BIRC5—uterine cancer	3.6e-05	0.00105	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.6e-05	0.00105	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.6e-05	0.00105	CbGpPWpGaD
Vinorelbine—Rash—Doxorubicin—uterine cancer	3.58e-05	0.000282	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—uterine cancer	3.58e-05	0.000282	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—uterine cancer	3.56e-05	0.00028	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—uterine cancer	3.52e-05	0.00103	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—uterine cancer	3.37e-05	0.000266	CcSEcCtD
Vinorelbine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.35e-05	0.000975	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.3e-05	0.000962	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.27e-05	0.000951	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.16e-05	0.00092	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—uterine cancer	3.15e-05	0.000917	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1B—uterine cancer	3.12e-05	0.000908	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	3.08e-05	0.000896	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.05e-05	0.000888	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CCL2—uterine cancer	3.04e-05	0.000885	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CCL2—uterine cancer	3.04e-05	0.000885	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.97e-05	0.000866	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.95e-05	0.000858	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.93e-05	0.000855	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CCL2—uterine cancer	2.93e-05	0.000854	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.93e-05	0.000853	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.92e-05	0.00085	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.89e-05	0.000841	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CCL2—uterine cancer	2.84e-05	0.000827	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1B—uterine cancer	2.79e-05	0.000812	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CCL2—uterine cancer	2.78e-05	0.000809	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.77e-05	0.000807	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—EP300—uterine cancer	2.74e-05	0.000797	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.67e-05	0.000777	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—uterine cancer	2.61e-05	0.00076	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.58e-05	0.000752	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.5e-05	0.000728	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CCL2—uterine cancer	2.49e-05	0.000726	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—EP300—uterine cancer	2.45e-05	0.000713	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CXCL8—uterine cancer	2.4e-05	0.000699	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CXCL8—uterine cancer	2.4e-05	0.000699	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—uterine cancer	2.38e-05	0.000695	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.36e-05	0.000688	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CXCL8—uterine cancer	2.32e-05	0.000675	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1B—uterine cancer	2.31e-05	0.000673	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CCL2—uterine cancer	2.28e-05	0.000664	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—EP300—uterine cancer	2.27e-05	0.000661	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CXCL8—uterine cancer	2.25e-05	0.000654	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CTNNB1—uterine cancer	2.21e-05	0.000645	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CTNNB1—uterine cancer	2.21e-05	0.000645	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CXCL8—uterine cancer	2.2e-05	0.00064	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.19e-05	0.000637	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.18e-05	0.000636	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.16e-05	0.000629	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CTNNB1—uterine cancer	2.14e-05	0.000623	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1B—uterine cancer	2.11e-05	0.000615	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—EP300—uterine cancer	2.07e-05	0.000604	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CTNNB1—uterine cancer	2.07e-05	0.000603	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—EP300—uterine cancer	2.03e-05	0.000591	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CTNNB1—uterine cancer	2.03e-05	0.00059	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CXCL8—uterine cancer	1.97e-05	0.000574	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NDUFB11—uterine cancer	1.91e-05	0.000556	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SRD5A2—uterine cancer	1.91e-05	0.000556	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—EP300—uterine cancer	1.85e-05	0.00054	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.84e-05	0.000536	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CTNNB1—uterine cancer	1.82e-05	0.00053	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CXCL8—uterine cancer	1.8e-05	0.000525	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.8e-05	0.000524	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.8e-05	0.000524	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—uterine cancer	1.75e-05	0.00051	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CTNNB1—uterine cancer	1.66e-05	0.000485	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.6e-05	0.000466	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.48e-05	0.000432	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—uterine cancer	1.45e-05	0.000423	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.4e-05	0.000408	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—STAR—uterine cancer	1.38e-05	0.000402	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.38e-05	0.000402	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.37e-05	0.000398	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—uterine cancer	1.33e-05	0.000387	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.3e-05	0.000379	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.3e-05	0.000379	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—STAR—uterine cancer	1.3e-05	0.000379	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.23e-05	0.000359	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.18e-05	0.000343	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.18e-05	0.000343	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—POLD1—uterine cancer	1.08e-05	0.000315	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.05e-05	0.000305	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—POLD1—uterine cancer	1.02e-05	0.000297	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.01e-05	0.000295	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.63e-06	0.000281	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKR1C1—uterine cancer	9.54e-06	0.000278	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.32e-06	0.000271	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—RRM2—uterine cancer	9.03e-06	0.000263	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—DCN—uterine cancer	8.76e-06	0.000255	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—RRM2—uterine cancer	8.51e-06	0.000248	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.5e-06	0.000248	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—STAR—uterine cancer	8.5e-06	0.000248	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—DCN—uterine cancer	8.26e-06	0.000241	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP11A1—uterine cancer	8.26e-06	0.000241	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.87e-06	0.000229	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKR1C3—uterine cancer	7.8e-06	0.000227	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP11A1—uterine cancer	7.78e-06	0.000227	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKR1C3—uterine cancer	7.35e-06	0.000214	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—POLD1—uterine cancer	6.67e-06	0.000194	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.24e-06	0.000182	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—STK11—uterine cancer	6.07e-06	0.000177	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP19A1—uterine cancer	6.07e-06	0.000177	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—STK11—uterine cancer	5.72e-06	0.000167	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.72e-06	0.000167	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—RRM2—uterine cancer	5.56e-06	0.000162	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—DCN—uterine cancer	5.4e-06	0.000157	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.09e-06	0.000148	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.8e-06	0.00014	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—uterine cancer	4.56e-06	0.000133	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—uterine cancer	4.3e-06	0.000125	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—STK11—uterine cancer	3.74e-06	0.000109	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.74e-06	0.000109	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.81e-06	8.19e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—uterine cancer	2.54e-06	7.4e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—EP300—uterine cancer	2.42e-06	7.05e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—uterine cancer	2.39e-06	6.97e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—EP300—uterine cancer	2.28e-06	6.65e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—uterine cancer	1.79e-06	5.22e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.69e-06	4.92e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—uterine cancer	1.56e-06	4.56e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—EP300—uterine cancer	1.49e-06	4.35e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—uterine cancer	1.46e-06	4.26e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—uterine cancer	1.38e-06	4.02e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.1e-06	3.22e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—uterine cancer	9.02e-07	2.63e-05	CbGpPWpGaD
